idecabtagene vicleucel
bms,2seventy bio
['mmsm', 'multiple myeloma', 'ide-cel', 'karmma', 'idecabtagene']
congress l #ash22 lauren peres, describes racial and ethic differences in treatment outcomes of rrmm patients treated with soc ide-cel. presenting data from 215 patients, it was found 34% had high risk cytogenetics, and that 43% were penta-refractory #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma